Skip to main content

News

Filter by:
  • 20240229_SCKCEN-Impact medical discharge on environment-Water treatment plant.jpg
    29 February '24

    SCK CEN sheds light on the long-term effects of radioisotopes in rivers and enhances protection for humans and nature

    New method for assessing the impact of medical radiopharmaceuticals on the environment

    When you receive a diagnosis or treatment involving medical radioisotopes in the hospital, a small amount of radioactivity ends up in the sewer after your restroom visit. But what if we use more of these medical substances in the future? Will the existing protective measures still be effective? Research conducted by SCK CEN, the Belgian Nuclear Research Center, provides a way to assess the safety of these discharges. As part of the European SINFONIA project, experts proactively investigated the potential long-term effects of hospital wastewater on the environment and human health. The result is a new methodology for more accurately assessing the possible impact on people, animals, and the environment. “This approach is particularly useful for predicting the impact of future new medications on the ecosystem and proactively adjusting regulations as needed,” emphasizes Jordi Vives i Batlle, an expert in impact studies at SCK CEN.

  • 20240214_SCK-CEN-x-CRM-Group---SMELD
    13 February '24

    Nuclear melting furnace also receives green light from Europe

    SCK CEN and CRM Group boost the circular economy in dismantling by constructing a nuclear furnace 

    The European Commission has given the final go-ahead for the development of the Belgian melting furnace for research purposes. The furnace will encourage the creation of a circular economy in nuclear dismantling, by enabling larger quantities of metal to be given a second life than can possibly be achieved using the melting technologies currently available. As the nuclear research centre SCK CEN and the Centre for Metallurgical Research (CRM Group) jointly stated, “This decision by the European Union reconfirms the social importance of our plan.” 

  • SCK  CEN  -  Lancering Pantera (2022)
    13 February '24

    PanTera signs agreement with Bayer for the supply of actinium-225

    Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients

    PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, today announces the signing of a capacity reservation agreement with Bayer for the supply of actinium-225 (225Ac) starting in the second half of 2024.